Objective: The objective of this study was to examine the strength and direction of the association between urinary symptoms and both poor quality sleep and daytime sleepiness among women with urgency urinary incontinence.
Methods:
A planned secondary analysis of baseline characteristics of participants in a multicenter, double-blinded, 12-week randomized controlled trial of pharmacologic therapy for urgency-predominant urinary incontinence in ambulatory women self-diagnosed by the 3 Incontinence Questions was performed. Urinary symptoms were assessed by 3-day voiding diaries. Quality of sleep was assessed using the Pittsburgh Sleep Quality Index (PSQI) and daytime sleepiness using the Epworth Sleepiness Scale.
Results: Of the 640 participants, mean (SD) age was 56 (±14) years and 68% were white. Participants reported an average of 3.9 (±3.0) urgency incontinence episodes per day and 1.3 (±1.3) episodes of nocturia per night. At baseline, 57% had poor sleep quality (PSQI score, >5) and 17% reported daytime sleepiness (Epworth Sleepiness Scale score, >10). Most women (69%) did not use sleeping medication during the prior month, whereas 13% reported use of sleeping medication 3 or more times per week. An increase in total daily incontinence episodes, total daily urgency incontinence episodes, total daily micturitions, and moderate to severe urge sensations were all associated with higher self-report of poor sleep quality according to the PSQI (all P ≤ 0.01). Higher scores on the Bother Scale and the Health-Related Quality of Life for overactive bladder on the Overactive Bladder Questionnaire were similarly associated with higher rates of poor sleep quality (both P ≤ 0.01). In subgroup analysis of those who took sleeping medications less than twice a week, there was still a significant relationship between incontinence measures and quality of sleep as measured by the PSQI. In multivariable analyses, greater frequency of nighttime urgency incontinence was associated with poor sleep quality (P = 0.03).
Conclusions: Among ambulatory women with urgency urinary incontinence, poor sleep quality is common and greater frequency of incontinence is associated with a greater degree of sleep dysfunction. Women seeking urgency urinary incontinence treatment should be queried about their sleeping habits so that they can be offered appropriate interventions.
Key Words: urgency urinary incontinence, quality of sleep, daytime sleepiness (Female Pelvic Med Reconstr Surg 2017;24: 76-81) U rinary incontinence is common among women in the United States with a prevalence rate of up to 77%. 1 Between 26% and 61% of women will seek care for urinary incontinence. [2] [3] [4] Although urinary incontinence is not associated with an increased mortality, 5 it has significant adverse impact on quality of life, sexual function, medical morbidity, and caregiver burden. [6] [7] [8] Nocturia, a symptom frequently reported with urgency urinary incontinence, is a common symptom associated with many sleep disorders 9 and in a population-based study out of Europe was the most common cause of sleep disturbance. 10 Disordered sleep is multifaceted, and the International Classification of Sleep Disorders lists 7 major categories with more than 60 distinct diagnosis. Because sleep disorders are associated with a wide range of diagnosis, it is difficult to determine an overall prevalence; however, the Institute of Medicine estimates that 50 to 70 million Americans chronically suffer from disorders of sleep and wakefulness representing around 20% of the population. 11 Other common causes of sleep dysfunction in the United States include moderate to severe obstructive sleep apnea, which affects around 10% of the population, and restless leg syndrome, which affects 5% of the population. about women with nocturia may not be applicable to those with overactive bladder. 12 In particular, it is not clear whether incontinence has a direct impact on sleep independent of nocturia, or whether the severity of sleep disturbance may be proportional to the severity or frequency of incontinence. Ultimately, we sought to identify women at highest risk for dysfunctional sleep to guide care providers in identifying patients who may need additional screening and interventions. The goals of this study were 2-fold: first, determine the prevalence of poor sleep quality and daytime sleepiness among women with urgency predominant urinary incontinence and, second, determine the strength and direction of the associations between urinary symptoms and sleep outcomes.
MATERIALS AND METHODS

Participants
Participants were recruited as part of a multicenter, doubleblinded, 12-week randomized placebo-controlled trial of oral pharmacological therapy for urgency-predominant incontinence in women self-diagnosed by the simple 3 Incontinence Questions. Study methods for the parent trial have been reported previously. 13 In brief, the study population included women aged 18 years and older with self-reported urgency or mixed urgency predominant urinary incontinence, with at least 3 episodes of urgency urinary incontinence on a 3-day bladder diary. Women were excluded if they self-reported complex medical histories that would require a specialist evaluation for incontinence before initiating pharmacological therapy. Whereas women taking sleeping medication were eligible for enrollment, those receiving treatment for urgency urinary incontinence were excluded. All patients from the parent trial were included in this secondary analysis.
Measures
At the initial visit, participants completed questionnaires on demographic characteristics (eg, age, race or ethnicity, education), health-related habits (eg, smoking, alcohol consumption), medication use, reproductive (eg, parity, menopause status), medical history (eg, diabetes, hypertension, stroke, chronic liver disease), surgical history (eg, previous hysterectomy), and incontinence (eg, age of onset of incontinence and duration [in years] of incontinence).
Sleep outcomes were measured by the Pittsburgh Sleep Quality Index (PSQI), 14 and daytime sleepiness was assessed by Epworth Sleepiness Scale (ESS). 15 The PSQI is a self-reported questionnaire that assesses sleep quality over a 1-month period and consists of 19-items weighted on a 0 to 3 interval scale. The scales are classified into 7 components including sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleeping medication, and daytime dysfunction. A global score is calculated by totaling the 7 component scores providing an overall score ranging from 0 to 21 with lower scores indicative of better sleep quality. The ESS is a self-reported questionnaire that assesses daytime sleepiness and the participant's probability of falling asleep in 8 different situations on a scale from 0 to 3 with a total score from 0 to 24. 15, 16 At baseline, women also completed a validated 3-day voiding diary in which they recorded each time they experienced incontinence or voided into the toilet, classified incontinence episodes by type (urgency, mixed, other), and rated the degree of urgency associated with each episode (none, mild, moderate, or severe). 17 Participants completed the Patient Perception of Bladder Condition, a validated single-item global measure of patients' subjective impression of their current urinary problems. 18 Participants also completed the Overactive Bladder Questionnaire (OAB-q), a 33-item condition-specific measure designed to assess the impact of overactive bladder symptoms. The OAB-q contains a symptom bother subscale (8-item scale) and a Health-Related Quality of Life subscale (25-item scale). The score for each of OAB-q domain is summed and adjusted such that they range from zero to 100 with higher scores indicating more severe symptoms or better quality of life. 19 
Statistical Analysis
For this planned secondary data analysis, poor sleep quality was defined as PSQI score of greater than 5 (diagnostic sensitivity of 89.6% and specificity of 86.5% in distinguishing poor compared with good sleepers).
14 Daytime sleepiness was defined by an ESS of greater than 10 because this has been shown to indicate significant daytime sleepiness. 16 Baseline demographics, health history, and lower urinary tract symptoms were compared between groups using χ 2 or Kurskal-Wallis. Multivariable analysis was performed controlling for clinical site and smoking status. Relationships between sleep quality and the number of urinary incontinence episodes and number of voids were examined by plotting the rate of poor sleep quality for each number of events and testing for a linear trend in logistic regression models. Additional multivariable modeling was performed by including each lower urinary tract symptoms (number of daytime urgency urinary incontinence episodes, daytime stress urinary incontinence episodes, nighttime urgency urinary incontinence episodes, stress urinary incontinence, and nonurinary incontinence voids and average urgency ratings) to determine the independent contribution of each to poor sleep quality. Analyses were also conducted excluding respondents who used sleep medication frequently (≥3 times per week). A P value of <0.05 was considered significant. Analyses were performed in SAS 9.4 (SAS Institute, Cary, NC).
RESULTS
Of the 645 participants enrolled, mean (SD) age was 56 (±14) years and 68% were white. Women reported an average of 3.9 (±3.0) urgency incontinence episodes per day and 1.3 (±1.3) episodes of nocturia per night. Six-hundred forty women completed the PSQI questionnaire with 371 (58%) reporting poor sleep quality (PSQI, >5); 643 completed the ESS questionnaire with 107 (17%) reporting daytime sleepiness (ESS score, >10). The use of sleep medications was not common in our cohort, and 441 (69%) reported no use of sleep medications in the past month, whereas 13% reported use of sleep medication three or more times per week.
No significant difference in age, race/ethnicity, marital status, menopausal status, or parity was detected between participants with and without poor sleep quality as defined by PSQI (Table 1) . Participants with poor sleep quality were less likely to report their overall health as excellent or very good (70.6 vs 90.0%; P < 0.01) and more likely to report current cigarette smoking (17.3 vs 10.4%, P = 0.04). When controlling for clinical site and smoking status, we found the same significant relationships between lower urinary tract symptoms and sleep quality ( Table 2) . Participants with poor sleep quality also reported more total incontinence episodes per day (5.03 vs 4.17; P < 0.01), more total urgency incontinence episodes per day (4.18 vs 3.48, P < 0.01), and greater frequency of daytime, nighttime, and total micturitions (10.3 vs 9.6 episodes; P = 0.01). Urge sensation was more common among those with poor sleep quality (P < 0.01). On the OAB-q, participants with poor sleep quality reported higher scores representing greater impact of their incontinence (40.3 vs 31.4, P < 0.01). In subscale analysis of the OAB-q, women with poor quality sleep also reported higher scores on the bother scale and Health-Related Quality of Life scale.
Participants with daytime sleepiness (ESS score, >10) were less likely to report their overall health to be excellent or very good compared with those with normal daytime sleepiness (69.2% vs 80.6%, P < 0.01) ( Table 3 ). There were no significant differences in measures of incontinence, including total incontinence episodes, urgency incontinence episodes, micturitions, urge sensations, or OAB-q when stratified by daytime sleepiness.
We also analyzed the strength of the relationship between lower urinary tract symptoms and poor quality sleep. Test for linear trend using 1 degree of freedom found a positive relationship between poor sleep quality according to the PSQI and increasing total urgency urinary incontinence episodes per night (P = 0.01) (Fig. 1) . For example, 73% of participants with 3 episodes of urgency incontinence per night met the threshold for poor sleep quality, as opposed to 53% of participants with 1 episode per night. We similarly found a significant relationship between poor sleep quality according to the PSQI and increasing voids per night (P = 0.02) (Fig. 2) . A total of 65% of participants with 3 episodes of nocturia per night met the threshold for poor sleep quality, as opposed to 52% of participants with no episodes of nocturia. We did not find a significant relationship between either frequency of nighttime urgency incontinence episodes or nocturia and daytime sleepiness as measured by the ESS.
In a multivariable analysis controlling for different lower urinary tract symptoms, only nighttime urgency incontinence remained significantly associated with PSQI (P = 0.03, data not shown). Subset analysis was completed excluding those who use sleeping medication regularly (≥3 times per week). The results for this analysis were similar to those in the entire cohort.
DISCUSSION
This study demonstrated the high prevalence of poor sleep quality among women with urgency urinary incontinence and provides new evidence that the severity of incontinence correlates with the degree of sleep disturbance. Because poor sleep quality has been associated with depression, 20 dementia, 21 cardiovascular disease, 22 and mortality, 23, 24 it is important to identify individuals with poor sleep to refer them to appropriate treatment.
Nocturia is one of the most common reasons for waking up at night, 25 and a number of studies have demonstrated a correlation between nocturia and poor sleep quality. [26] [27] [28] [29] [30] These studies, however, have tended to focus specifically on elderly populations where nocturia is most common with less attention to reproductive age and midlife women. Moreover, these studies have not consistently examined other measures of incontinence that also may have the potential to influence sleep outcomes among women in the community.
This study is unique in that it assesses a wide variety of incontinence measures demonstrating that not only are nighttime incontinence episodes and nighttime micturition associated with *ESS is a self-reported scale that assesses daytime sleepiness and assesses the participant's probability of falling asleep in 8 different situations on a scale from 0 to 3 with a total score from 0 to 24. Score greater than 10 is indicative of significant daytime sleepiness.
†Participants reported their perceptions of their overall health status as poor, satisfactory, good, very good, or excellent. poor sleep quality but also daytime incontinence and daytime urgency episodes are similarly associated with poor quality sleep. In a multivariable model controlling for lower urinary tract symptoms, only nighttime urgency incontinence was significantly associated with PSQI, suggesting that nighttime urgency urinary incontinence is the primary driver of poor quality sleep. Although we examined both sleep quality using the PSQI and daytime sleepiness with the ESS, we found that our incontinence measures were correlated only with sleep quality using the PSQI. Prior studies have demonstrated an association between nocturia and ESS score. 31 It is possible that we did not see a significant relationship between ESS score and incontinence measures owing to limited sample size because the study was not powered specifically to address daytime sleepiness. Although not statistically significant, there was a nonsignificant trend toward greater daytime sleepiness with increasing frequency of incontinence. It is also possible that we may not have found a significant relationship between daytime sleepiness and nocturia because the frequency of lower urinary tract symptoms was common in our population and there were very few respondents with no or minimal nocturia. Our results may therefore demonstrate a ceiling effect.
In addition to incontinence measures, other demographic characteristics including smoking status were found to be associated with poor sleep quality. Characteristics that have previously been associated with poor quality sleep include poor overall health 32, 33 and sleep apnea. 34, 35 Similarly, it was observed that respondents who reported poor overall health were more likely to report poor sleep quality. Although we did not specifically assess sleep apnea, it has been suggested that smoking is a risk factor for sleep-disordered breathing such as sleep apnea 36 and our study did find that current cigarette smoking was associated with worse quality sleep.
The major strengths of this study include a large sample size with information on multiple demographic and clinical characteristics as well as detailed information about a variety of urinary tract symptoms. There are several limitations to our study. This study looked specifically at women with urgency-predominant urinary incontinence and excluded patients with stress only or stress-predominant mixed incontinence or those with urinary urgency in the absence of incontinence, and our results may not be generalizable to these populations. This study also excluded participants with major comorbidities that might warrant further evaluation by an urogynecologist before initiation of pharmacologic therapy; therefore, our population may not be entirely generalizable.
In conclusion, this study demonstrates the overall high prevalence of abnormal sleep among those with urgency urinary incontinence and suggests that worsening urgency urinary incontinence is associated with worse quality sleep. Given the known adverse effects of poor quality sleep on health outcomes and quality of life, it is important that healthcare providers who are treating patients with incontinence inquire about their sleeping habits so that they can be offered appropriate treatment or referrals. In addition, treating incontinence may also help improve sleep quality among women with both bothersome conditions.
